K153272 is an FDA 510(k) clearance for the INTRACEPT Flexible Bi-Polar RF Probe and Easy Access Instrument Set. Classified as Probe, Radiofrequency Lesion (product code GXI), Class II - Special Controls.
Submitted by Relievant Medsystems (Redwood City, US). The FDA issued a Cleared decision on July 9, 2016 after a review of 240 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4725 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.